{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:06:21Z","timestamp":1767848781088,"version":"3.49.0"},"reference-count":38,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3892\/etm.2017.4862","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T06:25:01Z","timestamp":1501655101000},"page":"3153-3158","source":"Crossref","is-referenced-by-count":11,"title":["Elevated levels of soluble fractalkine and increased expression of CX3CR1 in neuropsychiatric systemic lupus erythematosus"],"prefix":"10.3892","volume":"14","author":[{"given":"Ling","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoye","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunde","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunle","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"key":"key20180108135443_b1-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"key20180108135443_b2-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"key20180108135443_b3-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","article-title":"IL-36 promotes myeloid cell infiltration, activation and inflammatory activity in skin","volume":"192","author":"Foster","year":"2014","journal-title":"J Immunol"},{"key":"key20180108135443_b4-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A new class of membrane-bound chemokine with a CX3C motif","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature"},{"key":"key20180108135443_b5-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"F207","DOI":"10.1152\/ajprenal.00482.2009","article-title":"Fractalkine expression and CDl6+ monocyte accumulation in glomerular 1esions: association with their severity and diversity in lupus models","volume":"299","author":"Nakatani","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20180108135443_b6-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.ajkd.2007.04.012","article-title":"Elevated levels of fractalkine expression and accumulation of CDl6+ monocyte in glomerui of active lupus nephritis","volume":"50","author":"Yoshimoto","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"key20180108135443_b7-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"key20180108135443_b8-etm-0-0-4862","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease. International study group for Beh\u00e7et's disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"key20180108135443_b9-etm-0-0-4862","first-page":"79","article-title":"Effect of different temperature and different stored time on concentration and purity of total RNA isolation","volume":"11","author":"Zhang","year":"2013","journal-title":"Shi Yan Ji Shu Yu Guan Li"},{"key":"key20180108135443_b10-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/096120339900800609","article-title":"Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI","volume":"8","author":"Formiga","year":"1999","journal-title":"Lupus"},{"key":"key20180108135443_b11-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaut.2012.05.021","article-title":"Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction","volume":"39","author":"Boissier","year":"2012","journal-title":"J Autoimmunity"},{"key":"key20180108135443_b12-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1002\/art.22208","article-title":"Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis","volume":"54","author":"Matsunawa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key20180108135443_b13-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.21042","article-title":"Elevated levels of soluble fractalkine in active systemic lupus erythematosus: Potential involvement in neuropsychiatric manifestations","volume":"52","author":"Yajima","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key20180108135443_b14-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/ard.2005.051276","article-title":"Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus","volume":"65","author":"Sato","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key20180108135443_b15-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/rheumatology\/kem168","article-title":"Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis-possible role in vascular inflammation","volume":"46","author":"Bjerkeli","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"key20180108135443_b16-etm-0-0-4862","first-page":"72","article-title":"Elevated serum levels of soluble CX3CL1 in patients with microscopic polyangiitis","volume":"27","author":"Matsunawa","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"key20180108135443_b17-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000320566","article-title":"Genistein suppression of TNF-alpha-induced fractalkine expression in endothelial cells","volume":"26","author":"Sung","year":"2010","journal-title":"Cell Physiol Biochem"},{"key":"key20180108135443_b18-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jlb.67.4.577","article-title":"NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha and LPS","volume":"67","author":"Garcia","year":"2000","journal-title":"J Leukoc Biol"},{"key":"key20180108135443_b19-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-61779-139-0_10","article-title":"Assessment of the recycling of the membrane-bound chemokine, CX3CL1","volume":"748","author":"Patel","year":"2011","journal-title":"Methods Mol Biol"},{"key":"key20180108135443_b20-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.188.8.1413","article-title":"Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow","volume":"188","author":"Fong","year":"1998","journal-title":"J Exp Med"},{"key":"key20180108135443_b21-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.4049\/jimmunol.164.8.4313","article-title":"CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms","volume":"164","author":"Goda","year":"2000","journal-title":"J Immunol"},{"key":"key20180108135443_b22-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0165-5728(03)00117-6","article-title":"Neuronal injury regulates fractalkine: Relevance for HIV-1 associated dementia","volume":"138","author":"Erichsen","year":"2003","journal-title":"J Neuroimmunol"},{"key":"key20180108135443_b23-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/42491","article-title":"Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation","volume":"387","author":"Pan","year":"1997","journal-title":"Nature"},{"key":"key20180108135443_b24-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1073\/pnas.090017497","article-title":"Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival","volume":"97","author":"Meucci","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108135443_b25-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.4049\/jimmunol.163.3.1628","article-title":"Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia","volume":"163","author":"Maciejewski-Lenoir","year":"1999","journal-title":"J Immunol"},{"key":"key20180108135443_b26-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2353\/ajpath.2010.100265","article-title":"CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models","volume":"177","author":"Lee","year":"2010","journal-title":"Am J Pathol"},{"key":"key20180108135443_b27-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1073\/pnas.95.18.10896","article-title":"Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia","volume":"95","author":"Harrison","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108135443_b28-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1471-4159.2009.06253.x","article-title":"Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro","volume":"110","author":"Lyons","year":"2009","journal-title":"J Neurochem"},{"key":"key20180108135443_b29-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-8993(03)02867-1","article-title":"Production and neuroprotective functions of fractalkine in the central nervous system","volume":"979","author":"Mizuno","year":"2003","journal-title":"Brain Res"},{"key":"key20180108135443_b30-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"RC87","DOI":"10.1523\/JNEUROSCI.20-15-j0004.2000","article-title":"Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage","volume":"20","author":"Chapman","year":"2000","journal-title":"J Neurosci"},{"key":"key20180108135443_b31-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-5793(98)00562-6","article-title":"Oxidative stress and hypoxia\/reoxygenation trigger CD95 (APO-1\/Fas) ligand expression in microglial cells","volume":"429","author":"Vogt","year":"1998","journal-title":"FEBS Lett"},{"key":"key20180108135443_b32-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4049\/jimmunol.165.1.397","article-title":"The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia","volume":"165","author":"Boehme","year":"2000","journal-title":"J Immunol"},{"key":"key20180108135443_b33-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(98)00005-8","article-title":"Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis","volume":"86","author":"Jiang","year":"1998","journal-title":"J Neuroimmunol"},{"key":"key20180108135443_b34-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jns.2011.11.011","article-title":"Fractalkine (CX3CL1) levels in patients with Beh\u00e7et's disease and neuro-Beh\u00e7et's disease","volume":"315","author":"Ceyla","year":"2012","journal-title":"J Neurol Sci"},{"key":"key20180108135443_b35-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jneuroim.2013.02.008","article-title":"Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice","volume":"257","author":"Mattison","year":"2012","journal-title":"J Neuroimmunol"},{"key":"key20180108135443_b36-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1046\/j.1523-1755.1999.00604.x","article-title":"Prevention of crescenticglomerolonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication","volume":"2","author":"Feng","year":"1999","journal-title":"Kidney Int"},{"key":"key20180108135443_b37-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.21007","article-title":"Antagonist of fractalkine(CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL\/lpr mice","volume":"52","author":"Inoue","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key20180108135443_b38-etm-0-0-4862","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1189\/jlb.0308158","article-title":"An engineered CX3CR1 antagonist endowed with anti-inflammatory activity","volume":"86","author":"Dorgham","year":"2009","journal-title":"J Leukoc Biol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T20:20:56Z","timestamp":1692908456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.4862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,8,2]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.3892\/etm.2017.4862"],"URL":"https:\/\/doi.org\/10.3892\/etm.2017.4862","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]}}}